Medicine and Dentistry
Acute Leukemia
100%
Anticoagulant Protein
11%
APC
11%
Arteriosclerosis Obliterans
7%
Artery Thrombosis
7%
Assay
11%
Association
11%
Biological Marker
100%
Bleeding
11%
Blood Clotting Factor
11%
Blood Sampling
11%
Bosutinib
14%
Brain Ischemia
7%
Cell Adhesion Molecule
35%
Cell Line
7%
Chronic Myelogenous Leukemia
14%
Complication
22%
Conflict
7%
Dasatinib
57%
Diagnostic Test
22%
Disseminated Intravascular Coagulation
100%
Edoxaban
100%
Endothelial Leukocyte Adhesion Molecule 1
21%
Exploratory Behavior
11%
Fluorescence in Situ Hybridization
20%
Hematologic Malignancy
11%
Hemostat
11%
Imatinib
14%
Immunoassay
11%
Inpatient
100%
Lipid Storage
7%
Lupus Anticoagulant
11%
Nilotinib
35%
Patient
77%
Pharmacodynamics
22%
Photography
7%
Ponatinib
42%
Procoagulant
100%
Reagent
33%
Side Effect
7%
Therapeutic Procedure
22%
Thrombin
22%
Thrombocyte Poor Plasma
11%
Thrombophilia
11%
Thromboplastin
22%
Thrombosis
100%
Tyrosine-Kinase Inhibitor
100%
Umbilical Vein
7%
Venous Thromboembolism
11%
Wound Closure
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
20%
Acute Leukemia
100%
Anazolene Sodium
6%
Anticoagulant Agent
100%
Anticoagulant Protein
12%
Antithrombin
12%
Antivitamin K
20%
APC
12%
Blood Clotting Factor
12%
Bosutinib
13%
Direct Oral Anticoagulant
100%
Disseminated Intravascular Clotting
100%
Drug
20%
Edoxaban
100%
Electrophoresis
6%
Gelatin
26%
Gelatinase A
46%
Gelatinase B
46%
Hematologic Malignancy
11%
Hemolysis
14%
Lupus Anticoagulant
12%
Matrix Metalloproteinase
20%
Pharmacodynamics
45%
Pharmacokinetics
20%
Protein S
12%
Random Effects Model
16%
Randomized Controlled Trial
16%
Rupture
100%
Thromboembolism
40%
Thrombophilia
12%
Toxic Injury
20%